Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis

作者: Annamaria Molino , Giuseppe Pelosi , Monica Turazza , Loris Sperotto , Andrea Bonetti

DOI: 10.1023/A:1005747711084

关键词:

摘要: Background: The presence in bone marrow of cells which react with monoclonal antibodies against tumor-associated antigens has been proposed over the last few years as a new prognostic factor breast cancer patients. Patients and methods: Bone aspirates were obtained from 109 stage I II patients during or 2–4 weeks after primary surgery. samples processed for leukocyte separation on Ficoll-Hypaque gradient then used to prepare cytospin slides immunocytochemical analysis. stained pool (MoAbs) recognize tumor associated antigens, using alkaline phosphatase anti-alkaline method. median follow-up was 36 months (range 15–62); 22 relapsed 7 died. Results: Thirty-four (31.1%) had MoAb positive cells. 28/74 (37.9%) who aspirate taken surgery 6/35 (17.1%) it (p = 0.055). No association found between positivity tumour size, nodal status, menopausal estrogen receptor proliferative index. prognosis: log-rank test 0.291 > 0.5) OS 0.023 DFS; hazard ratio (positive vs negative) 1.51 (95% CI: 0.33–6.86) 0.93 DFS 0.35–2.45). Conclusions: In our series, did not correlate parameters prognosis. Of interest is relative excess when

参考文章(26)
McNeil Bj, Adelstein Sj, Gray Eb, Wilson Re, Pace Pd, Preoperative and follow-up bone scans in patients with primary carcinoma of the breast. Surgery gynecology & obstetrics. ,vol. 147, pp. 745- ,(1978)
AA Ross, BW Cooper, HM Lazarus, W Mackay, TJ Moss, N Ciobanu, MS Tallman, MJ Kennedy, NE Davidson, D Sweet, Detection and Viability of Tumor Cells in Peripheral Blood Stem Cell Collections From Breast Cancer Patients Using Immunocytochemical and Clonogenic Assay Techniques Blood. ,vol. 82, pp. 2605- 2610 ,(1993) , 10.1182/BLOOD.V82.9.2605.BLOODJOURNAL8292605
M. B. Brown, Wilfrid Joseph Dixon, BMDP statistical software University of California Press. ,(1983)
I J Diel, M Kaufmann, R Goerner, S D Costa, S Kaul, G Bastert, Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. Journal of Clinical Oncology. ,vol. 10, pp. 1534- 1539 ,(1992) , 10.1200/JCO.1992.10.10.1534
S Ménard, P Squicciarini, A Luini, V Sacchini, D Rovini, E Tagliabue, P Veronesi, B Salvadori, U Veronesi, MI Colnaghi, Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features. British Journal of Cancer. ,vol. 69, pp. 1126- 1129 ,(1994) , 10.1038/BJC.1994.221
N Harbeck, M Untch, L Pache, W Eiermann, Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. British Journal of Cancer. ,vol. 69, pp. 566- 571 ,(1994) , 10.1038/BJC.1994.103
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Annamaria Molino, Monica Zardini, Felice Pasini, Alessandro Perini, Gian Luigi Cetto, Marco Colombatti, Giuseppe Tridente, Franco Bonetti, Giuseppe Pelosi, Dino Veneri, A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow Cancer. ,vol. 67, pp. 1033- 1036 ,(1991) , 10.1002/1097-0142(19910215)67:4<1033::AID-CNCR2820670428>3.0.CO;2-H
ELDA TAGLIABUE, GIULIANA PORRO, PAOLO BARBANTI, GABRIELLA DELLA TORRE, SYLVIE MENARD, FRANCO RILKE, SERENELLA CERASOLI, MARIA I. COLNAGHI, Improvement of tumor cell detection using a pool of monoclonal antibodies. Hybridoma. ,vol. 5, pp. 107- 115 ,(1986) , 10.1089/HYB.1986.5.107
D.P. Dearnaley, M.G. Ormerod, J.P. Sloane, Micrometastases in breast cancer: long-term follow-up of the first patient cohort. European Journal of Cancer and Clinical Oncology. ,vol. 27, pp. 236- 239 ,(1991) , 10.1016/0277-5379(91)90504-7